Glenmark Pharmaceuticals Claimed Company
Developer of pharmaceutical molecular entities, formulations and active pharmaceutical ingredients created to deal with issues of child health care. The company's pharmaceutical molecular entities, formulations and active pharmaceutical ingredients offer generic drugs manufactured in the US, Argentina, Czech Republic and India, enabling patients to be treated for conditions such as inflammation, pain and oncology. read more
HR or Marketing? Claim Your Free Employer Account
George Sager — VP Finance at Glenmark Pharmaceuticals
Executive Bio
George Sager serves as the VP Finance of Glenmark Pharmaceuticals. George Sager and the Glenmark Pharmaceuticals executive team are rated a B by 3 employees.
Executive Team Culture Ratings from Glenmark Pharmaceuticals Employees
TOP
30%
Glenmark Pharmaceuticals' Executive Team scores in the Top 30%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at Glenmark PharmaceuticalsNot Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at Glenmark PharmaceuticalsGlenmark Pharmaceuticals' Executive Team at a Glance
Based on 4 ratings, Glenmark Pharmaceuticals' employees are satisfied with their Executive Team and give them a “B” or 70/100.
Glenmark Pharmaceuticals' Executive Team ranks in the Top 30% of other companies on Comparably that also have 10,000+ Employees.
×